| Title |
Use of atypical antipsychotics in the elderly: a clinical review
|
|---|---|
| Published in |
Clinical Interventions in Aging, August 2014
|
| DOI | 10.2147/cia.s63942 |
| Pubmed ID | |
| Authors |
Pietro Gareri, Cristina Segura-García, Valeria Graziella Laura Manfredi, Antonella Bruni, Paola Ciambrone, Gregorio Cerminara, Giovambattista De Sarro, Pasquale De Fazio |
| Abstract |
The use of atypical antipsychotic drugs in the elderly has become wider and wider in recent years; in fact, these agents have novel receptor binding profiles, good efficacy with regard to negative symptoms, and reduced extrapyramidal symptoms. However, in recent years, the use of both conventional and atypical antipsychotics has been widely debated for concerns about their safety in elderly patients affected with dementia and the possible risks for stroke and sudden death. A MEDLINE search was made using the words elderly, atypical antipsychotics, use, schizophrenia, psychosis, mood disorders, dementia, behavioral disorders, and adverse events. Some personal studies were also considered. This paper reports the receptor binding profiles and the main mechanism of action of these drugs, together with their main use in psychiatry and the possible adverse events in elderly people. |
X Demographics
The data shown below were collected from the profiles of 11 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 1 | 9% |
| Belgium | 1 | 9% |
| Turkey | 1 | 9% |
| United States | 1 | 9% |
| United Kingdom | 1 | 9% |
| Unknown | 6 | 55% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 9 | 82% |
| Practitioners (doctors, other healthcare professionals) | 2 | 18% |
Mendeley readers
The data shown below were compiled from readership statistics for 289 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Japan | 1 | <1% |
| Spain | 1 | <1% |
| Germany | 1 | <1% |
| Taiwan | 1 | <1% |
| Unknown | 285 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 37 | 13% |
| Student > Master | 31 | 11% |
| Researcher | 30 | 10% |
| Other | 27 | 9% |
| Student > Ph. D. Student | 23 | 8% |
| Other | 66 | 23% |
| Unknown | 75 | 26% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 107 | 37% |
| Pharmacology, Toxicology and Pharmaceutical Science | 24 | 8% |
| Psychology | 18 | 6% |
| Agricultural and Biological Sciences | 11 | 4% |
| Neuroscience | 10 | 3% |
| Other | 28 | 10% |
| Unknown | 91 | 31% |
Attention Score in Context
This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 June 2021.
All research outputs
#3,053,140
of 25,654,806 outputs
Outputs from Clinical Interventions in Aging
#314
of 1,977 outputs
Outputs of similar age
#29,200
of 240,709 outputs
Outputs of similar age from Clinical Interventions in Aging
#7
of 46 outputs
Altmetric has tracked 25,654,806 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,977 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.3. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 240,709 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 46 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 84% of its contemporaries.